PREVAIL- flunixin meglumine injection, solution United States - English - NLM (National Library of Medicine)

prevail- flunixin meglumine injection, solution

mwi veterinary supply co - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - horse: prevail® is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: prevail® is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. prevail® is also indicated for the control of inflammation in endotoxemia. horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flu

FLURISO- isoflurane liquid United States - English - NLM (National Library of Medicine)

fluriso- isoflurane liquid

mwi veterinary supply co - isoflurane (unii: cys9akd70p) (isoflurane - unii:cys9akd70p) - isoflurane 1 ml in 1 ml - isoflurane, usp is used for induction and maintenance of general anesthesia in horses and dogs. isoflurane, usp is contraindicated in horses and dogs with known sensitivity to isoflurane or to other halogenated agents.

NEOMYCIN AND POLYMYXIN B SULFATES, AND BACITRACIN ZINC- neomycin sulfate, polymyxin b sulfate and bacitracin zinc ointment United States - English - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates, and bacitracin zinc- neomycin sulfate, polymyxin b sulfate and bacitracin zinc ointment

mwi - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i) - neomycin 3.5 mg in 1 g - neomycin and polymyxin b sulfates and bacitracin zinc ophthalmic ointment, usp is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. neomycin and polymyxin b sulfates and bacitracin zinc ophthalmic ointment, usp is contraindicated in individuals who have shown hypersensitivity to any of its components.

OFLOXACIN solution/ drops United States - English - NLM (National Library of Medicine)

ofloxacin solution/ drops

mwi - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication (see warnings ).

NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE- neomycin sulfate, polymyxin b sulfate, and dexamethasone ointment United States - English - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates and dexamethasone- neomycin sulfate, polymyxin b sulfate, and dexamethasone ointment

mwi - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - neomycin 3.5 mg in 1 g - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/enterobacter s

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE- neomycin sulfate and polymyxin b sulfate, bacitracin zinc United States - English - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates, bacitracin zinc and hydrocortisone- neomycin sulfate and polymyxin b sulfate, bacitracin zinc

mwi - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin 3.5 mg in 1 g - neomycin and polymyxin b sulfates, bacitracin zinc and hydrocortisone ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology, microbiology). the particular anti-infective drugs in this product

NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC- neomycin sulfate, polymyxin b sulfate and bacitracin zinc ointment United States - English - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates and bacitracin zinc- neomycin sulfate, polymyxin b sulfate and bacitracin zinc ointment

mwi - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i) - neomycin 3.5 mg in 1 g - neomycin and polymyxin b sulfates and bacitracin zinc ophthalmic ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. neomycin and polymyxin b sulfates and bacitracin zinc ophthalmic ointment is contraindicated in those individuals who have shown hypersensitivity to any of its components.

CALPLUS injection, solution United States - English - NLM (National Library of Medicine)

calplus injection, solution

mwi (vetone) - calcium borogluconate (unii: 6915g2pqi0) (calcium cation - unii:2m83c4r6zb), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), magnesium gluconate (unii: t42nad2khc) (magnesium cation - unii:t6v3lhy838), phosphorus (unii: 27ylu75u4w) (phosphorus - unii:27ylu75u4w) - calcium borogluconate 26 g in 100 ml - for intravenous use in cattle to treat milk fever, and in calcium, phosphorus, magnesium and glucose deficiency in animals.

HYPERTONIC SALINE injection, solution United States - English - NLM (National Library of Medicine)

hypertonic saline injection, solution

mwi (vetone) - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698) - sodium chloride 7.2 g in 100 ml - for use in replacement therapy of sodium, chloride and water which may become depleted in many diseases. for animal use only.

SULFADIMETHOXINE 107G- sulfadimethoxine sodium powder, for solution United States - English - NLM (National Library of Medicine)

sulfadimethoxine 107g- sulfadimethoxine sodium powder, for solution

mwi - sulfadimethoxine sodium (unii: 49dg2b481w) (sulfadimethoxine - unii:30cpc5ldex) - sulfadimethoxine sodium 94.6 g in 107 g - ndc  13985-717-10 vetone sulfadimethoxine 107g soluble powder antibacterial each packet contains 3.34 oz. (94.6 g) sulfadimethoxine in the form of the soluble sodium salt and disodium edetate. caution:  federal (usa) law restricts this drug to use by or on the order of a licensed veterinarian. restricted drug (california) - use only as directed. not for human use. anada #200-238 approved by fda for broiler and replacement chickens only - use for the treatment of disease outbreaks of coccidiosis, fowl cholera, and infectious coryza. for meat-producing turkeys only - use for the treatment of disease outbreaks of coccidiosis, and fowl cholera. for dairy calves, dairy heifers, and beef cattle - use for the treatment of shipping fever complex and bacterial pneumonia associated with pasteurella spp. sensitive to sulfadimethoxine; and calf diphtheria and foot rot associated with sphaerophorus necrophorus sensitive to sulfadimethoxine. net contents: 3.77 oz (107g) distributed by: mwi boise, id 83705 www.v